Skip to main content
Premium Trial:

Request an Annual Quote

CLC Bio Acquires Molegro

NEW YORK (GenomeWeb News) – CLC bio announced today that it has acquired Danish bioinformatics firm Molegro for an undisclosed sum.

Molegro's products focus on molecular docking including prediction and analysis of protein-ligand interactions, screening of compound databases for activities against a receptor, and determination of molecule similarity. CLC said the deal is part of its strategy to expand its bioinformatics offerings beyond next-generation sequencing.

"We have always had a strong focus on the science behind our software, and joining CLC bio allows us to become part of a strong analysis platform and focus even more on developing the next generation of molecular docking products," Molegro CEO René Thomsen said in a statement. "CLC bio has demonstrated the capability to build an elaborate analysis platform and distribute it internationally, and exactly that competence is the best way to take the features of Molegro's software to the next level."

CLC added that it intends to continue to invest in the development of the acquired protein-ligand docking and data modeling software.